Kricolon Tablet

Adult dose

The recommended dose of this drug for colonic cleansing in adults is 32 tablets (equivalent to 48g of sodium phosphate), taken orally with approximately 2 liters of water as follows: 1. The evening before the examination: Take a total of 20 tablets, taking 4 tablets with approximately 240mL of water every 15 minutes. 2. On the day of the examination: Starting 3~5 hours before the examination, take a total of 12 tablets, taking 4 tablets with approximately 240mL of water every 15 minutes. Patients receiving this drug should maintain adequate hydration before, after, and during administration of this drug. If this drug has previously been taken for colonic cleansing, do not take it again within 7 days. No additional enema solutions or laxatives are needed, and do not take additional medicines, particularly products containing sodium phosphate.

This medication is an oral sodium phosphate preparation used to cleanse the bowel prior to colonoscopy. When taking this medication, special caution is required for patients with impaired kidney function, elderly patients over 55 years, patients in a dehydrated state, or those with heart and kidney diseases. Patients with certain conditions such as congenital megacolon, heart disease, gastrointestinal obstruction, or toxic colitis should not use this medication. During treatment, it is important to drink plenty of water, and if there are symptoms such as vomiting or dehydration, intravenous therapy should be received at a hospital. This medication may cause side effects such as diarrhea, abdominal pain, and vomiting, and very rarely, severe side effects such as kidney damage, cardiac arrhythmia, and seizures have been reported. When taken with other medications, the risk of electrolyte imbalance or side effects may increase, so consultation with a doctor or pharmacist is necessary. Pregnant or breastfeeding women should only use this medication if absolutely necessary, and it is recommended not to use it in children under 18 years of age due to unknown safety. In case of overdose, serious electrolyte abnormalities and complications may occur, and immediate medical treatment should be sought. This medication should be stored out of reach of children, and it is safer not to transfer it to another container.

Acute phosphate nephropathy, permanent impairment of renal function, need for long-term dialysis, dehydration, abdominal distension, abdominal pain, nausea, vomiting, dizziness, headache, renal failure, nephrocalcinosis, cardiac arrhythmias, seizures, tonic-clonic seizures, loss of consciousness, aphthous ulcers, acute exacerbation of chronic inflammatory diseases, anaphylaxis, rash, itching, urticaria, throat tightness, bronchospasm, dyspnea, angioedema, dysphagia, abnormal sensations and swelling of the lips and tongue, facial edema, renal impairment, increased blood urea nitrogen, increased creatinine, acute renal failure, renal tubular necrosis

This medication should be stored in a tightly closed container to prevent moisture. It is best stored at room temperature between 1°C and 30°C.

Appearance

White rectangular tablets

Package unit

32 tablets/bottle